Income Tax Expense (Benefit) in USD of Akebia Therapeutics, Inc. from Q1 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Akebia Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2013 to Q3 2025.
  • Akebia Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $615K.
  • Akebia Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Akebia Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
  • Akebia Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

Akebia Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $615K +$615K Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q3 2024 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q4 2020 $0 $0 +$6.6M Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$6.6M $0 +$1.28M Jul 1, 2020 Sep 30, 2020 10-K 2021-02-25
Q2 2020 -$7.88M $0 +$845K Apr 1, 2020 Jun 30, 2020 10-K 2021-02-25
Q1 2020 -$8.72M $0 +$2.76M Jan 1, 2020 Mar 31, 2020 10-K 2021-02-25
Q4 2019 -$6.6M +$21.7M +76.7% Dec 30, 2019 Dec 31, 2019 10-K 2020-03-12
Q4 2019 -$11.5M -$1.75M +$26.6M +93.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$33.2M -$1.28M -$1.28M Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$31.9M -$845K -$845K Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$31.1M -$2.76M -$2.76M Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$28.3M -$28.3M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-09
Q3 2017 $0 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q3 2016 $0 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $0 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 $0 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q3 2014 $0 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $0 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $0 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12

Akebia Therapeutics, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K/A 2023-08-28
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
2020 $0 +$6.63M Jan 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
2019 -$6.63M +$21.7M +76.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$28.3M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.